Zimmer Biomet Holdings Inc  

(Public, NYSE:ZBH)   Watch this stock  
Find more results for NYSE:ZMH
115.77
+0.77 (0.67%)
Apr 29 - Close
NYSE real-time data - Disclaimer
Currency in USD
Range 114.35 - 116.44
52 week 88.27 - 117.77
Open 115.00
Vol / Avg. 1.97M/1.33M
Mkt cap 23.00B
P/E 161.72
Div/yield 0.24/0.83
EPS 0.72
Shares 198.83M
Beta 0.97
Inst. own 99%
May 5, 2016
Zimmer Biomet Holdings Inc at Deutsche Bank Health Care Conference - 12:50PM EDT - Add to calendar
May 4, 2016
Zimmer Holdings Inc Annual Shareholders Meeting (Estimated) - 8:00AM EDT - Add to calendar
May 3, 2016
Zimmer Biomet Holdings Inc Annual Shareholders Meeting - 8:00AM EDT - Add to calendar
Apr 28, 2016
Q1 2016 Zimmer Biomet Holdings Inc Earnings Call
Apr 28, 2016
Q1 2016 Zimmer Biomet Holdings Inc Earnings Release
Mar 16, 2016
Zimmer Biomet Holdings Inc at Barclays Global Healthcare Conference
More events from DailyFinance »    

Key stats and ratios

Q4 (Dec '15) 2015
Net profit margin 6.55% 2.44%
Operating margin 11.04% 7.79%
EBITD margin - 33.54%
Return on average assets 1.89% 0.79%
Return on average equity 5.12% 1.79%
Employees 17,500 -
CDP Score - 62 E

Address

345 E Main St
WARSAW, IN 46580-2746
United States - Map
+1-574-2676131 (Phone)
+1-302-6365454 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Zimmer Biomet Holdings, Inc., formerly Zimmer Holdings, Inc. is a musculoskeletal healthcare company. The Company designs, manufactures and markets orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; spine, bone healing, craniomaxillofacial and thoracic products; dental implants, and related surgical products. The Company manages its operations through three geographic segments: the Americas, comprising principally of the United States and includes other North, Central and South American markets; Europe, comprising principally of Europe and includes the Middle East and African markets; and Asia Pacific, comprising primarily of Japan and includes other Asian and Pacific markets. The Company markets and sells products through three channels: direct to healthcare institutions, such as hospitals or direct channel accounts; through stocking distributors and healthcare dealers, and directly to dental practices and dental laboratories.

Officers and directors

David C. Dvorak President, Chief Executive Officer, Director
Age: 52
Bio & Compensation  - Reuters
Daniel P. Florin Chief Financial Officer, Senior Vice President
Age: 51
Bio & Compensation  - Reuters
Stuart G. Kleopfer President, Americas
Age: 53
Bio & Compensation  - Reuters
Katarzyna Mazur-Hofsaess M.D. Ph.D. President, Europe, Middle East and Africa
Age: 52
Bio & Compensation  - Reuters
Sang Yi President, Asia Pacific
Age: 54
Bio & Compensation  - Reuters
Chad F. Phipps Senior Vice President, General Counsel, Secretary
Age: 44
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Tony W. Collins Chief Accounting Officer, Vice President, Corporate Controller
Age: 47
Bio & Compensation  - Reuters
Adam Rudolph Johnson Group President, Spine, Dental, CMF and Thoracic
Age: 38
Bio & Compensation  - Reuters
David A. Nolan Jr. Group President of Biologics, Extremities, Sports Medicine, Surgical, Trauma, Foot and Ankle and Bone Healing
Age: 50
Bio & Compensation  - Reuters
Daniel E. Williamson Group President, Joint Reconstruction
Age: 50
Bio & Compensation  - Reuters